Clal Biotechnology Industries (XTAE:CBI) Total Stockholders Equity : ₪99.36 Mil (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Clal Biotechnology Industries Total Stockholders Equity?

Clal Biotechnology Industries's Total Stockholders Equity for the quarter that ended in Dec. 2023 was ₪99.36 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Clal Biotechnology Industries's Book Value per Share for the quarter that ended in Dec. 2023 was ₪0.63. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Clal Biotechnology Industries's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.36.

Clal Biotechnology Industries Total Stockholders Equity Historical Data

The historical data trend for Clal Biotechnology Industries's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clal Biotechnology Industries Total Stockholders Equity Chart

Clal Biotechnology Industries Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

223.60

306.35

172.59

126.03

99.36

Clal Biotechnology Industries Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															150.62	131.95	126.03	134.14	99.36

Clal Biotechnology Industries (XTAE:CBI) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Clal Biotechnology Industries's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(99.358	-	0)	/	156.846
	=	0.63

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Clal Biotechnology Industries's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(5.441	+	30.316)	/	99.358
	=	0.36

Clal Biotechnology Industries Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Clal Biotechnology Industries's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Clal Biotechnology Industries (XTAE:CBI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clal Biotechnology Industries Ltd (XTAE:CBI) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Azrieli Center, Triangle Building, 45th Floor, Tel Aviv, ISR, 67023

Website

http://www.cbi.co.il

Clal Biotechnology Industries Ltd is a life sciences investment company. The company invests in companies ranging from seed to maturity, both public and private. Its portfolio of investments includes from heavy industry to biotechnology, hi-tech and energy companies.